WHO reassures on the effectiveness of vaccines (4/12)
The WHO has reassured the public that the current Covid-19 vaccines should remain effective against this variant to prevent symptomatic and severe forms of the disease. However, it calls for vigilance, especially in Asia where the variant has become dominant. Hong Kong reported that key Covid-19 surveillance indicators were at their highest level in a year, prompting authorities to tighten hygiene measures.
© Shutterstock
Ad
Ad
Increase in positive test rates in Hong Kong (5/12)
The percentage of respiratory samples testing positive for SARS-CoV-2 in Hong Kong has doubled in one month, from 6.21% to 13.66%. In addition, the viral load in wastewater has almost doubled, reaching 710,000 copies/litre. Despite these alarming numbers, there is no indication at this time that NB.1.8.1 causes more severe forms of the disease.© Shutterstock
Ad
Ad Identification
of the NB.1.8.1 variant in France and the United States (6/12)
In France, the variant has been identified four times, according to the National Reference Center in Lyon. In the United States, travelers from European countries, including France, tested positive between the end of April and mid-May. The European Centre for Disease Prevention and Control has not yet placed the variant under surveillance, but is monitoring its evolution closely.
© Shutterstock
Ad
Ad
Low risk to public health but increased transmissibility (7/12)
According to the WHO, the additional risk to public health posed by NB.1.8.1 is considered low globally. Nevertheless, the mutations observed could increase its transmissibility, which requires further studies. Scientists are concerned that these mutations could reduce the effectiveness of antibodies and promote immune evasion.
© Shutterstock
